CIRM Funded Clinical Trials

Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects with Chronic Ischemic Subcortical Stroke

Disease Area: 
Investigator:
CIRM Grant:
Award Value:
$11,998,988
Trial Sponsor:
Stanford University
Trial Stage: 
Phase 1
Trial Status: 
Recruiting
Targeted Enrollment:
30
ClinicalTrials.gov ID: